ArticleJournal of managed care & specialty pharmacy2021
Optimal treatment sequence for targeted immune modulators for the treatment of moderate to severe ulcerative colitis.
Lisa M Bloudek et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.